XML 281 R49.htm IDEA: XBRL DOCUMENT v3.23.1

Business Segments (Tables)

12 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Information about our Operating and Reportable Segments

The tables below summarize information about our operating and reportable segments.

			Year Ended March 31, 2023
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Total segment revenues*			$	973,774					$	153,951											$	1,127,725
Cost of sales			441,844						60,587												502,431
Gross profit			531,930						93,364												625,294
Advertising and marketing			123,926						21,135												145,061
Contribution margin			$	408,004					$	72,229											480,233
Other operating expenses**																					502,648
Operating loss																					$	(22,415)

*Intersegment revenues of $4.3 million were eliminated from the North American OTC Healthcare segment.

**Other operating expenses for the year ended March 31, 2023 includes a tradename impairment charge of $321.4 million and a goodwill impairment charge of $48.8 million.

			Year Ended March 31, 2022
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Total segment revenues*			$	967,881					$	118,931											$	1,086,812
Cost of sales			419,162						47,004												466,166
Gross profit			548,719						71,927												620,646
Advertising and marketing			138,714						18,629												157,343
Contribution margin			$	410,005					$	53,298											463,303
Other operating expenses																					133,384
Operating income																					$	329,919

* Intersegment revenues of $3.0 million were eliminated from the North American OTC Healthcare segment.

			Year Ended March 31, 2021
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Total segment revenues*			$	849,319					$	94,046											$	943,365
Cost of sales			359,100						36,793												395,893
Gross profit			490,219						57,253												547,472
Advertising and marketing			122,857						17,732												140,589
Contribution margin			$	367,362					$	39,521											406,883
Other operating expenses																					109,481
Operating income																					$	297,402

*Intersegment revenues of $3.2 million were eliminated from the North American OTC Healthcare segment.

Information about our Revenues from Similar Product Groups

The tables below summarize information about our segment revenues from similar product groups.

			Year Ended March 31, 2023
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Analgesics			$	116,582					$	2,680											$	119,262
Cough & Cold			100,218						26,770												126,988
Women's Health			231,754						19,597												251,351
Gastrointestinal			156,957						69,626												226,583
Eye & Ear Care			151,879						19,197												171,076
Dermatologicals			119,822						3,919												123,741
Oral Care			85,542						12,085												97,627
Other OTC			11,020						77												11,097
Total segment revenues			$	973,774					$	153,951											$	1,127,725

			Year Ended March 31, 2022
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Analgesics			$	117,868					$	1,455											$	119,323
Cough & Cold			86,855						20,225												107,080
Women's Health			249,136						15,373												264,509
Gastrointestinal			152,191						52,368												204,559
Eye & Ear Care			149,454						13,995												163,449
Dermatologicals			117,173						3,213												120,386
Oral Care			85,239						12,282												97,521
Other OTC			9,965						20												9,985
Total segment revenues			$	967,881					$	118,931											$	1,086,812

			Year Ended March 31, 2021
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Analgesics			$	117,775					$	1,367											$	119,142
Cough & Cold			56,158						14,483												70,641
Women's Health			252,535						15,562												268,097
Gastrointestinal			124,755						36,381												161,136
Eye & Ear Care			99,774						10,635												110,409
Dermatologicals			103,998						3,085												107,083
Oral Care			88,903						12,528												101,431
Other OTC			5,421						5												5,426
Total segment revenues			$	849,319					$	94,046											$	943,365

Segment Revenue by Geographic Area

Our total segment revenues by geographic area are as follows:

			Year Ended March 31,
			2023						2022						2021
United States			$	953,222					$	910,106					$	799,038
Rest of world			174,503						176,706						144,327
Total			$	1,127,725					$	1,086,812					$	943,365

Allocation of Long-Term Assets to Segments

Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows:

March 31, 2023 (In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Goodwill			$	498,936					$	28,617											$	527,553
Intangible assets
Indefinite-lived			2,092,852						76,050												2,168,902
Finite-lived			154,552						18,439												172,991
Intangible assets, net			2,247,404						94,489												2,341,893
Total			$	2,746,340					$	123,106											$	2,869,446

March 31, 2022 (In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Goodwill			$	548,291					$	30,685											$	578,976
Intangible assets
Indefinite-lived			2,391,517						85,042												2,476,559
Finite-lived			198,353						21,723												220,076
Intangible assets, net			2,589,870						106,765												2,696,635
Total			$	3,138,161					$	137,450											$	3,275,611

Goodwill and Intangible Assets by Geographic Areas

Our goodwill and intangible assets by geographic area are as follows:

			Year Ended March 31,
			2023						2022
United States			$	2,746,340					$	3,138,161
Rest of world			123,106						137,450
Total			$	2,869,446					$	3,275,611

X

- Definition

[Table Text Block] for Goodwill and Intangible Assets by Geographic Areas [Table]

+ References

No definition available.

+ Details

Name:	pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock
Namespace Prefix:	pbh_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

+ Details

Name:	us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph a
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

+ Details

Name:	us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration